Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Titles
NEW
 Top 50 Non-Healthcare Titles
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Eye Melanoma Global Market Report 2025
Request Sample Buy Now
Global Eye Melanoma Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Eye Melanoma Global Market Report 2025

By Site (Uvea, Sclera, Retina), By Diagnosis (Imaging, Biopsy, Eye Exam), By Treatment (Surgery, Radiation Therapy, Targeted Therapy, Immunotherapy, Other Treatment), By End User (Hospitals And Clinics, Academic Institutes) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Eye Melanoma Market Overview

• Eye Melanoma market size has reached to $9.1 billion in 2024

• Expected to grow to $13.8 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%

• Growth Driver: Rising Prevalence Of Eye Cancer Boosts Growth Prospects For The Eye Melanoma Market

• Market Trend: Pioneering Advances In Eye Melanoma Treatment For Unresectable Or Metastatic Uveal Melanoma

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Eye Melanoma Market?

Eye melanoma is a type of cancer that develops in the melanocytes, the cells that produce melanin within the eye. It occurs in different parts of the eye, including the uvea, the iris, and the choroid. Eye melanoma is the most common primary intraocular cancer in adults and can cause vision problems, changes in eye color, and other symptoms depending on its location and size.

The main types of eye melanoma occur in the uvea, sclera, and retina. The uvea refers to the middle layer of the eye that consists of the iris, ciliary body, and choroid, which contain blood vessels that supply nutrients to the eye and various forms of radiation therapy, including plaque brachytherapy, proton beam therapy, and stereotactic radiosurgery, are used to target and shrink uveal melanomas. They are diagnosed with imaging, biopsy, and eye exams and treated with treatments such as surgery, radiation therapy, targeted therapy, immunotherapy, and others provided by end users such as hospitals, clinics, and academic institutes.

Eye Melanoma Market Size and growth rate 2025 to 2029: Graph

What Is The Eye Melanoma Market Size 2025 And Growth Rate?

The eye melanoma market size has grown strongly in recent years. It will grow from $9.1 billion in 2024 to $9.86 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to increased awareness and early detection, aging population and sun exposure, rise in skin cancer incidence, development of targeted therapies, patient advocacy and support programs.

What Is The Eye Melanoma Market Growth Forecast?

The eye melanoma market size is expected to see strong growth in the next few years. It will grow to $13.8 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to continued public health initiatives, research in genetic and molecular profiling, global aging population trends. Major trends in the forecast period include integration of artificial intelligence (ai), emergence of targeted therapies, focus on rare disease drug development, patient-centric drug approval processes, advancements in diagnostic imaging, advancements in treatment modalities, technological innovations in imaging.

The forecast of 8.8% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. cancer care by increasing costs for plaque brachytherapy devices and ocular ultrasound systems imported from Israel and Germany, potentially delaying tumor management and raising oncology treatment expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Eye Melanoma Market Segmented?

1) By Site: Uvea, Sclera, Retina

2) By Diagnosis: Imaging, Biopsy, Eye Exam

3) By Treatment: Surgery, Radiation Therapy, Targeted Therapy, Immunotherapy, Other Treatment

4) By End User: Hospitals And Clinics, Academic Institutes

Subsegments:

1) By Uvea: Choroid Melanoma, Ciliary Body Melanoma, Iris Melanoma

2) By Sclera: Scleral Melanoma

3) By Retina: Retinal Melanoma

What Is Driving The Eye Melanoma Market? Rising Prevalence Of Eye Cancer Boosts Growth Prospects For The Eye Melanoma Market

The increasing prevalence of eye cancer is expected to propel the growth of the eye melanoma market going forward. Eye cancer refers to the development of abnormal and uncontrolled cell growth within the eye's structures. The growing recognition and effective management of early cases are creating a heightened need for specialized therapies and interventions, propelled by improved detection methods, increased awareness, and advancements in treatment options. For instance, in January 2023, according to the American Cancer Society, a US-based nonprofit cancer advocacy organization, the number of eye and orbital cancer cases increased to 3,490 in 2023, reflecting a growth of 5.12% from 3,320 in 2021. Therefore, the increasing prevalence of eye cancer will drive the growth of the eye melanoma industry.

What Is Driving The Eye Melanoma Market? Rising Geriatric Population Propels Growth In The Eye Melanoma Market

An increasing geriatric population is expected to boost the growth of the eye melanoma market going forward. The geriatric population refers to older adults, usually people older than 65. The incidence of eye melanoma, a type of eye cancer, increases with age. Older individuals are more likely to develop this condition due to prolonged exposure to environmental factors and genetic predispositions. With the expansion of the geriatric population, the potential number of individuals at risk for eye melanoma also rises. For instance, in October 2022, according to the data released by the World Health Organization, a US-based international organization, the proportion of the population aged 60 and above increased from 1 billion in 2021 to 1.4 billion in 2022. Further, the world's population of adults aged 60 and above will be doubled to 2.1 billion by 2050. Therefore, the increasing geriatric population will drive the growth of the eye melanoma industry.

Who Are The Major Players In The Global Eye Melanoma Market?

Major companies operating in the eye melanoma market report are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Sanofi S.A., GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Koninklijke Philips N.V., Carl Zeiss AG, Genentech Inc., Elekta Instrument AB, Brainlab AG, Optos Plc, Castle Biosciences Inc., Heidelberg Engineering, Nektar Therapeutics, RaySearch Laboratories AB, Nidek Co. Ltd., IDEAYA Biosciences, Immunocore Limited, Topcon Healthcare, Oraya Therapeutics Inc., Delcath Systems Inc.

What Are The Key Trends Of The Global Eye Melanoma Market? Pioneering Advances In Eye Melanoma Treatment For Unresectable Or Metastatic Uveal Melanoma

Major companies operating in the eye melanoma treatment sector are focused on developing innovative and specialized treatments, such as immunotherapies and targeted therapies, to enhance patient outcomes and quality of life. Immunotherapies and targeted therapies are novel treatment modalities that have recently begun to enter the oncology field. For instance, in January 2022, Immunocore Ltd., a UK-based biopharmaceutical company that focuses on research and development of biological drugs using soluble T-cell receptor technology, received approval from the U.S. Food and Drug Administration (FDA) for Kimmtrak (tebentafusp-tabn), a T-cell receptor therapeutic, which is the first therapy for individuals with unresectable or metastatic uveal melanoma (mUM). Kimmtrak is an immunotherapy that targets a specific protein called gp100, which is present on the surface of uveal melanoma (UM) cells. It activates the patient's immune system to eliminate melanoma by engaging specialized immune cells through engineered T-cell receptors, offering a precision-driven approach to cancer treatment.

Need data on a specific region in this market?
Request Customisation

What Are Latest Mergers And Acquisitions In The Eye Melanoma Market? Health Network One Acquires Premier Eye Care To Expand Ophthalmology Services And Provider Network

In January 2023, Health Network One, a US-based prominent specialty benefit management company, acquired a Premier Eye Care company for an undisclosed amount. With this acquisition, Health Network One aims to expand its provider network, enhance clinical quality, and drive innovation in ophthalmology services. Premier Eye Care, a US-based eye care services company, specializes in diagnosing and treating eye melanoma with various options like surgery, radiation, and laser therapy.

Regional Outlook For The Global Eye Melanoma Market

North America was the largest region in the eye melanoma market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Eye Melanoma Market?

The eye melanoma market consists of revenues earned by entities by providing fine needle aspiration (FNA) techniques, blood testing, and genetic testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The eye melanoma market also includes sales of drugs and therapeutics such as chemotherapy, cryotherapy, and photodynamic therapy (PDT). Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Eye Melanoma Industry?

The eye melanoma market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the eye melanoma industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Eye Melanoma Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $9.86 billion
Revenue Forecast In 2034 $13.8 billion
Growth Rate CAGR of 8.8% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Site: Uvea, Sclera, Retina
2) By Diagnosis: Imaging, Biopsy, Eye Exam
3) By Treatment: Surgery, Radiation Therapy, Targeted Therapy, Immunotherapy, Other Treatment
4) By End User: Hospitals And Clinics, Academic Institutes Subsegments: 1) By Uvea: Choroid Melanoma, Ciliary Body Melanoma, Iris Melanoma
2) By Sclera: Scleral Melanoma
3) By Retina: Retinal Melanoma
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co. Inc, AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Sanofi S.A., GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Koninklijke Philips N.V., Carl Zeiss AG, Genentech Inc., Elekta Instrument AB, Brainlab AG, Optos Plc , Castle Biosciences Inc., Heidelberg Engineering, Nektar Therapeutics, RaySearch Laboratories AB, Nidek Co. Ltd, IDEAYA Biosciences, Immunocore Limited , Topcon Healthcare, Oraya Therapeutics Inc., Delcath Systems Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Eye Melanoma Market Characteristics

3. Eye Melanoma Market Trends And Strategies

4. Eye Melanoma Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Eye Melanoma Growth Analysis And Strategic Analysis Framework

5.1. Global Eye Melanoma PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Eye Melanoma Market Growth Rate Analysis

5.4. Global Eye Melanoma Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Eye Melanoma Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Eye Melanoma Total Addressable Market (TAM)

6. Eye Melanoma Market Segmentation

6.1. Global Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Uvea

Sclera

Retina

6.2. Global Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Imaging

Biopsy

Eye Exam

6.3. Global Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Surgery

Radiation Therapy

Targeted Therapy

Immunotherapy

Other Treatment

6.4. Global Eye Melanoma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Clinics

Academic Institutes

6.5. Global Eye Melanoma Market, Sub-Segmentation Of Uvea, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Choroid Melanoma

Ciliary Body Melanoma

Iris Melanoma

6.6. Global Eye Melanoma Market, Sub-Segmentation Of Sclera, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Scleral Melanoma

6.7. Global Eye Melanoma Market, Sub-Segmentation Of Retina, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Retinal Melanoma

7. Eye Melanoma Market Regional And Country Analysis

7.1. Global Eye Melanoma Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Eye Melanoma Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Eye Melanoma Market

8.1. Asia-Pacific Eye Melanoma Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Eye Melanoma Market

9.1. China Eye Melanoma Market Overview

9.2. China Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Eye Melanoma Market

10.1. India Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Eye Melanoma Market

11.1. Japan Eye Melanoma Market Overview

11.2. Japan Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Eye Melanoma Market

12.1. Australia Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Eye Melanoma Market

13.1. Indonesia Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Eye Melanoma Market

14.1. South Korea Eye Melanoma Market Overview

14.2. South Korea Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Eye Melanoma Market

15.1. Western Europe Eye Melanoma Market Overview

15.2. Western Europe Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Eye Melanoma Market

16.1. UK Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Eye Melanoma Market

17.1. Germany Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Eye Melanoma Market

18.1. France Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Eye Melanoma Market

19.1. Italy Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Eye Melanoma Market

20.1. Spain Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Eye Melanoma Market

21.1. Eastern Europe Eye Melanoma Market Overview

21.2. Eastern Europe Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Eye Melanoma Market

22.1. Russia Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Eye Melanoma Market

23.1. North America Eye Melanoma Market Overview

23.2. North America Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Eye Melanoma Market

24.1. USA Eye Melanoma Market Overview

24.2. USA Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Eye Melanoma Market

25.1. Canada Eye Melanoma Market Overview

25.2. Canada Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Eye Melanoma Market

26.1. South America Eye Melanoma Market Overview

26.2. South America Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Eye Melanoma Market

27.1. Brazil Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Eye Melanoma Market

28.1. Middle East Eye Melanoma Market Overview

28.2. Middle East Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Eye Melanoma Market

29.1. Africa Eye Melanoma Market Overview

29.2. Africa Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Eye Melanoma Market Competitive Landscape And Company Profiles

30.1. Eye Melanoma Market Competitive Landscape

30.2. Eye Melanoma Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.3. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Merck & Co. Inc Overview, Products and Services, Strategy and Financial Analysis

30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Eye Melanoma Market Other Major And Innovative Companies

31.1. Bayer AG

31.2. Novartis AG

31.3. Bristol-Myers Squibb Company

31.4. AstraZeneca PLC

31.5. Sanofi S.A.

31.6. GlaxoSmithKline PLC

31.7. Eli Lilly and Company

31.8. Amgen Inc.

31.9. Koninklijke Philips N.V.

31.10. Carl Zeiss AG

31.11. Genentech Inc.

31.12. Elekta Instrument AB

31.13. Brainlab AG

31.14. Optos Plc 

31.15. Castle Biosciences Inc.

32. Global Eye Melanoma Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Eye Melanoma Market

34. Recent Developments In The Eye Melanoma Market

35. Eye Melanoma Market High Potential Countries, Segments and Strategies

35.1 Eye Melanoma Market In 2029 - Countries Offering Most New Opportunities

35.2 Eye Melanoma Market In 2029 - Segments Offering Most New Opportunities

35.3 Eye Melanoma Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Eye Melanoma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Eye Melanoma Market, Sub-Segmentation Of Uvea, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Eye Melanoma Market, Sub-Segmentation Of Sclera, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Eye Melanoma Market, Sub-Segmentation Of Retina, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Eye Melanoma Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Eye Melanoma Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Pfizer Inc. Financial Performance
  • Table 79: Johnson & Johnson Financial Performance
  • Table 80: F. Hoffmann-La Roche Ltd Financial Performance
  • Table 81: Merck & Co. Inc Financial Performance
  • Table 82: AbbVie Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Eye Melanoma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Eye Melanoma Market, Sub-Segmentation Of Uvea, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Eye Melanoma Market, Sub-Segmentation Of Sclera, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Eye Melanoma Market, Sub-Segmentation Of Retina, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Eye Melanoma Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Eye Melanoma Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Pfizer Inc. Financial Performance
  • Figure 79: Johnson & Johnson Financial Performance
  • Figure 80: F. Hoffmann-La Roche Ltd Financial Performance
  • Figure 81: Merck & Co. Inc Financial Performance
  • Figure 82: AbbVie Inc. Financial Performance

Next-Gen Primary Health Care Service : Market Forecast, Transformation, and Long-Term Trajectories

Read More About Next-Gen Primary Health Care Service : Market Forecast, Transformation, and Long-Term Trajectories

Progressive Ataxia And Weakness Disorders Growth Trajectory: Key Forecasts and Strategic Insights

Read More About Progressive Ataxia And Weakness Disorders Growth Trajectory: Key Forecasts and Strategic Insights

Prostate Cancer Nuclear Medicine Diagnostics Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Read More About Prostate Cancer Nuclear Medicine Diagnostics Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the Prostate Cancer Nuclear Medicine Diagnostics Market Landscape: Automated Parallel Capillary Electrophoresis Systems Transforming Protein Analysis In The Protein Chip Market

Read More About Emerging Trends Redefining the Prostate Cancer Nuclear Medicine Diagnostics Market Landscape: Automated Parallel Capillary Electrophoresis Systems Transforming Protein Analysis In The Protein Chip Market

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Blood Warmers Global Market Report 2024 – By Type (Portable blood warmers, Non-portable blood warmers), By Application (Surgery, Acute care, Newborn care, Homecare, Other Applications), By End-User (Hospitals Or Clinics,...

View Report

Colorectal Cancer Molecular Diagnostics Global Market Report 2025 – By Type (Instruments, Reagents And Kits, Services), By Technology (Polymerase Chain Reaction (PCR), Sequencing, Mass Spectrometry, Transcription Mediate...

View Report

Nasopharyngeal Carcinoma Treatment Global Market Report 2025 – By Types (Non-Keratinizing Undifferentiated Carcinoma, Non-Keratinizing Differentiated Carcinoma, Keratinizing Squamous Cell Carcinoma), By Drug (Ellence, Ta...

View Report

Anti-Aging Drugs Global Market Report 2025 – By Product (Serums, Creams, Gels, Other Products), By Drug Class (Hormonal Therapy, Antioxidants, Enzymes, Stem Cells), By Type (Injectable, Oral, Topical), By Ingredient (Ret...

View Report

Fruit and Vegetable Seeds Global Market Report 2025 – By Type (Tomato, Pepper, Onion, Cucumber, Lettuce, Melon, Carrot, Other Types ), By Trait (Genetically Modified, Conventional), By Family Type (Solanaceae, Cucurbit, ...

View Report

Hepatitis Diagnostic Tests Global Market Report 2025 – By Test Type (Blood Tests, Imaging Tests, Liver Biopsy), By Technology (Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests (RDTs), Polymerase Chain Re...

View Report

Animal Therapeutics And Diagnostics Global Market Report 2025 – By Animal Type (Companion Animals, Cattle, Pigs, Poultry, Sheep), By Product (Animal Diagnostics Products, Instruments, Consumables, Animal Therapeutics Pro...

View Report

Automotive Retrofit Electric Vehicle Powertrain Global Market Report 2025 – By Component Type (Inclusive Conversion Kit, Electric Motor, Battery, Controller, Charger, Other Components), By Vehicle type (Two Wheelers, Pas...

View Report

Frequently Asked Questions

Eye melanoma is a type of cancer that develops in the melanocytes, the cells that produce melanin within the eye. It occurs in different parts of the eye, including the uvea, the iris, and the choroid. Eye melanoma is the most common primary intraocular cancer in adults and can cause vision problems, changes in eye color, and other symptoms depending on its location and size. For further insights on this market, request a sample here

The market major growth driver - Rising Prevalence Of Eye Cancer Boosts Growth Prospects For The Eye Melanoma Market. For further insights on this market, request a sample here

The eye melanoma market size has grown strongly in recent years. It will grow from $9.1 billion in 2024 to $9.86 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to increased awareness and early detection, aging population and sun exposure, rise in skin cancer incidence, development of targeted therapies, patient advocacy and support programs. The eye melanoma market size is expected to see strong growth in the next few years. It will grow to " $13.8 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to continued public health initiatives, research in genetic and molecular profiling, global aging population trends. Major trends in the forecast period include integration of artificial intelligence (AI), emergence of targeted therapies, focus on rare disease drug development, patient-centric drug approval processes, advancements in diagnostic imaging, advancements in treatment modalities, technological innovations in imaging. For further insights on this market, request a sample here

The eye melanomamarket covered in this report is segmented –
1) By Site: Uvea; Sclera; Retina
2) By Diagnosis: Imaging; Biopsy; Eye Exam
3) By Treatment: Surgery; Radiation Therapy; Targeted Therapy; Immunotherapy; Other Treatment
4) By End User: Hospitals And Clinics; Academic Institutes Subsegments:
1) By Uvea: Choroid Melanoma; Ciliary Body Melanoma; Iris Melanoma
2) By Sclera: Scleral Melanoma
3) By Retina: Retinal Melanoma For further insights on this market, request a sample here

North America was the largest region in the eye melanoma market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the eye melanoma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on this market, request a sample here.

Major companies operating in the eye melanoma market report are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Sanofi S.A., GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Koninklijke Philips N.V., Carl Zeiss AG, Genentech Inc., Elekta Instrument AB, Brainlab AG, Optos Plc, Castle Biosciences Inc., Heidelberg Engineering, Nektar Therapeutics, RaySearch Laboratories AB, Nidek Co. Ltd., IDEAYA Biosciences, Immunocore Limited, Topcon Healthcare, Oraya Therapeutics Inc., Delcath Systems Inc.. For further insights on this market, request a sample here.

Major trends in this market include Pioneering Advances In Eye Melanoma Treatment For Unresectable Or Metastatic Uveal Melanoma. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Eye Melanoma Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top